heme → biliverdin — via heme oxygenase (HO-1 + HO-2); releases CO + Fe2+. Heme oxygenase (inducible HO-1, constitutive HO-2) opens the porphyrin ring, releasing carbon monoxide (the main endogenous CO source, a gasotransmitter) and Fe²⁺ for recycling. HO-1 is a key Nrf2-induced cytoprotective/antioxidant stress enzyme.
biliverdin → unconjugated-bilirubin — via biliverdin reductase. Biliverdin reductase yields unconjugated (indirect) bilirubin — lipophilic, albumin-bound in blood, and itself a potent antioxidant. Being lipid-soluble it can cross the blood–brain barrier, the basis of neonatal kernicterus risk.
unconjugated-bilirubin → conjugated-bilirubin — via UGT1A1 — GILBERT / CRIGLER-NAJJAR enzyme; ATAZANAVIR-INHIBITED. UGT1A1 glucuronidates bilirubin to the water-soluble conjugated form for biliary excretion. Reduced activity causes Gilbert syndrome (mild, common) and Crigler-Najjar (severe); the same enzyme is inhibited by atazanavir and performs many drug glucuronidations.
conjugated-bilirubin → urobilinogen — via intestinal bacterial deconjugation + reduction; excretion + EHC. Gut bacteria deconjugate and reduce bilirubin to urobilinogen; most exits as stercobilin (stool color) while some is reabsorbed (enterohepatic circulation) and renally excreted as urobilin (urine color). Biliary obstruction → pale stool with dark urine.